Barrier Reverse Convertible

Symbol: NMSRCH
ISIN: CH1282072896
Issuer:
Raiffeisen
Trade

Chart

    
    

SIX Structured Products trading

SIX Structured Products Bid Ask Notation
Please note that data is only available after start of trading.
Trading hours for this product: 9:15 – 17:15

Performance

Closing prev. day 101.82
Diff. absolute / % 0.00 0.00%

Determined prices

Last Price - Volume -
Time - Date -

More Product Information

Core Data

Name Barrier Reverse Convertible
ISIN CH1282072896
Valor 128207289
Symbol NMSRCH
Quotation in percent Yes
Coupon p.a. 7.40%
Coupon Premium 6.21%
Coupon Yield 1.19%
Type Multi Barrier Reverse Convertibles
SVSP Code 1230
Barrier reached No
COSI Product No
Exercise type American
Currency Swiss Franc
First Trading Date 29/12/2023
Date of maturity 29/12/2025
Last trading day 22/12/2025
Settlement Type Path-dependent
IRS 871m Not applicable
Currency safeguarded No
Pricing Dirty
Issuer Raiffeisen

Key data

Sideways yield p.a. -

market maker quality Date: 03/12/2025

Average Spread 0.80%
Last Best Bid Price 101.43 %
Last Best Ask Price 102.24 %
Last Best Bid Volume 250,000
Last Best Ask Volume 250,000
Average Buy Volume 250,000
Average Sell Volume 250,000
Average Buy Value 253,575 CHF
Average Sell Value 255,600 CHF
Spreads Availability Ratio 100.00%
Quote Availability 100.00%

Underlyings

Name Novartis AG Swiss Life Hldg. N Zurich Insurance Group AG Roche AG
ISIN CH0012005267 CH0014852781 CH0011075394 CH0012032048
Price 106.92 CHF 877.00 CHF 576.4000 CHF 310.4000 CHF
Date 05/12/25 17:19 05/12/25 17:19 05/12/25 17:19 05/12/25 17:19
Cap 84.84 CHF 579.60 CHF 440.70 CHF 244.30 CHF
Distance to Cap 22.28 299.4 136.5 67.1
Distance to Cap in % 20.80% 34.06% 23.65% 21.55%
Is Cap Level reached No No No No
Barrier 55.146 CHF 376.74 CHF 286.455 CHF 158.795 CHF
Distance to Barrier 51.974 502.26 290.745 152.605
Distance to Barrier in % 48.52% 57.14% 50.37% 49.01%
Is Barrier reached No No No No

Please wait...
The data push was deactivated due to a timeout. Please click "Refresh page" to continue.